PTH Comparison in Post Menopausal Women
NCT00543218
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis, Post-Menopausal
Interventions
DRUG:
teriparatide 20 micrograms/day subcutaneous
DRUG:
calcitonin 100 IU/day subcutaneous
Sponsor
Eli Lilly and Company